Dodda Brahmam

Dodda Brahmam

Auto-generated profile, based on publicly available information

Dodda Brahmam

Department of Anesthesiology, All India Institute of Medical Sciences, Mangalagiri, Atmakur, India

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2022 in Indian Journal of Critical Care Medicine
Verified
Journal Article
Open access
VGVikas Gupta
Vikas Gupta
JSJai Prakash Sharma
Jai Prakash Sharma
PSPranav Shrivastava
Pranav Shrivastava
SKSunaina Tejpal Karna
Sunaina Tejpal Karna
AKAlkesh Khurana
Alkesh Khurana
GBGankalyan Behera
Gankalyan Behera
Background: Tracheostomy is integral in long-term intensive care of coronavirus disease-2019 (COVID-19) patients. There is a paucity of studies on weaning outcomes and mortality after tracheostomy in COVID-19 in Indian scenario. Materials and methods: We conducted a retrospective, single-center, observational study of severe COVID-19 patients who underwent elective tracheostomy (n = 65) during critical care in a tertiary care institute in Central India from May 1, 2020, to April 30, 2021. Data were collected from Medical records, ICU charts, and follow-up visits by patient. A primary objective was to study the clinical characteristics, tracheostomy complications, weaning outcomes, and mortality at 28 and 60 days of ICU admission. We categorized the cohort into two groups (deceased and survivor) and studied association of clinical parameters with 28-day mortality. Cox Proportional regression analysis was applied to calculate the hazard ratio among the predictors of mortality with p value <0.05 as significant. Results: Elective tracheostomy was done in 69 of 436 (15.8%) patients on invasive mechanical ventilation, of which 65 were included. Tracheostomy was percutaneous in 45/65 (69%) and surgical in 20/65 (31%) with timing from intubation as early in 41/65 and late in 24/65 with most common indication as weaning failure followed by anticipated prolonged ventilation. Tracheostomy complications were present in 29/65 (45%) patients with no difference in complication rates between timing and type of tracheostomy. Downsizing, decannulation, and weaning were successful in 22%, 32 (49%), and 35/65 (54%) patients after tracheostomy. The 28-day mortality was 30/65 (46%). The fractional inspired oxygen concentration (FiO(2)) requirement in survivors was lower (0.4-0.6, p = 0.015) with a higher PaO2/FiO(2) ratio (118-200, p = 0.033). Early tracheostomy within 7 days of intubation was not associated with weaning or survival benefit. Conclusions: We suggest that tracheostomy should be delayed to after 7 days of intubation, especially till FiO(2) reduces to 0.5 with improvement in PaO2/FiO(2) for better outcomes and avoiding a wasted procedure (CTRI/2021/07/034768).

31 August 2022 in Indian Journal of Critical Care Medicine
Verified
Journal Article
Open access
SSSaurabh Saigal
Saurabh Saigal
GJGaurav Jain
Gaurav Jain
AAAbhijeet Anand
Abhijeet Anand
RPRajesh Panda
Rajesh Panda
SKSaiteja Kodamanchili
Saiteja Kodamanchili
SJSurya Jha
Surya Jha
Background and objectives: Major adverse cardiac events (MACE) are frequent in coronavirus disease-2019 (COVID-19). Remdesivir is used worldwide for treatment in COVID-19. In this retrospective observational study, our primary objective was to assess the impact of remdesivir administration on the incidence of MACE and associated 28 day survival in critically ill patients admitted for moderate to severe COVID-19 pneumonia. Patients and methods: We analyzed the data of 437 patients admitted in intensive care unit (ICU) and divided them into two groups: R group (received remdesivir at ICU admission) and NR group (nonremdesivir) or based on the occurrence of MACE in ICU. We followed the data until discharge, death, or 28 days postadmission. Our primary objective was to investigate the log-odds of survival with remdesivir administration and a correlation/regression analysis of MACE with remdesivir administration in all included patients. Results: The incidence of MACE was 72 among 437 patients, with 17 (9.3%) patients in R group vs 55 (21.8%) in NR group (p <0.001). On performing correlation analysis between MACE and remdesivir administration, significant correlation coefficient of -0.168 (p = 0.004) was obtained. On regression analysis, the odds ratio for occurrence of MACE with remdesivir administration was 0.362 (regression coefficient: -1.014, p <0.001). It indicates a 64% decrease in the log-odds of MACE and a 16% increase in the log-odds of survival with remdesivir administration. All 72 patients with MACE had expired, suggesting a high mortality risk with cardiac complications. The odds ratio for mortality due to MACE with remdesivir administration was 0.216 (regression coefficient: -1.530, p -<0.001). It indicates a 79% decrease in the log-odds of death due to MACE with remdesivir administration. Conclusion: Our study showed significant reduction in MACE and mortality benefit in patients who received remdesivir in comparison to standard treatment.

30 August 2022 in Indian Journal of Critical Care Medicine
Verified
Journal Article
Open access
RJRajnish Joshi
Rajnish Joshi
PSPooja Singh
Pooja Singh
AGAbhishek Goyal
Abhishek Goyal
SSSaurabh Saigal
Saurabh Saigal
APAbhijit Pakhare
Abhijit Pakhare
SKSagar Khadanga
Sagar Khadanga
Background: The outcomes in critical illness depend on disease severity, practice protocols, workload, and access to care. This study investigates the factors affecting outcomes in mechanically ventilated coronavirus disease-2019 acute respiratory distress syndrome (COVID-19 ARDS) patients admitted in a tertiary teaching hospital intensive care unit (ICU) in Central India with reference to different time periods in pandemic. This is one of the largest series of mechanically ventilated COVID-19 ARDS patients, globally. Methods: This retrospective cohort study classified the entire data into four time periods (Period 1: April 2020 to June 2020; Period 2: July 2020 to September 2020; Period 3: October 2020 to December 2020; and Period 4: January 2021 to April 2021). We performed a multivariable-adjusted analysis to evaluate predictors of mortality, adjusted for baseline-severity, sequential organ failure assessment (SOFA score) and time period. We applied mixed-effect binomial logistic regression to model fixed-effect variables with incremental complexity. Results: Among the 56 survivors (19.4%) out of 288 mechanically ventilated patients, there was an up-gradient of survival proportion (0, 18.2, 17.4, and 28.6%) in four time periods. Symptom-intubation interval (OR 1.16; 95% CI 1.03-1.31) and driving pressures (DPs) (OR 1.17; 95% CI 1.07-1.28) were significant predictors of mortality in the model having minimal AIC and BIC values. Patients aged above 60 years also had a larger effect, but statistically insignificant effect favoring mortality (OR 1.99; 95% CI 0.92-4.27). The most complex but less parsimonious model (with higher AIC/BIC) indicated the protective odds of high steroid on mortality (OR 0.59; 95% CI 0.59-0.82). Conclusion: The outcomes in mechanically ventilated COVID-19 ARDS patients are heterogeneous across time windows and may be affected by the complex interaction of baseline risk and critical care parameters. Indian Journal of Critical Care Medicine (2022): 10.5005/jp-journals-10071-24279

21 February 2026 in Indian Journal of Anaesthesia
Verified
Journal Article
Open access
MMMurala Madhuri
Murala Madhuri
DBDodda Brahmam
Dodda Brahmam
GBGhansham Biyani
Ghansham Biyani
HKHandattu M. Krishna
Handattu M. Krishna

18 March 2026 in Indian Journal of Critical Care Medicine
Verified
Journal Article
Open access
MRManoj Kumar R
Manoj Kumar R
DBDodda Brahmam
Dodda Brahmam
YSYugandhar Samireddypalle
Yugandhar Samireddypalle
AMArumulla Mithilesh
Arumulla Mithilesh
MMMurala Madhuri
Murala Madhuri
How to cite this article: Kumar RM, Brahmam D, Samireddypalle Y, Mithilesh A, Madhuri M. Correspondence Regarding: “A Prospective Comparative Study of Optic Nerve Sheath Diameter Measurement by Ultrasonography vs Computed Tomography Scan for the Detection of Elevated Intracranial Pressure in Patients with Acute Neurological Emergencies”. Indian J Crit Care Med 2026;30(3):262–263.